Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients
IntroductionCOVID-19 patients can develop autoantibodies against a variety of secreted and membrane proteins, including some expressed on lymphocytes. However, it is unclear what proportion of patients might develop anti-lymphocyte antibodies (ALAb) an…